2020
DOI: 10.21203/rs.3.rs-44882/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The relationship between time to surgery(TTS) after neoadjuvant chemotherapy (NAC)and survival in breast cancer patients: meta-analysis

Abstract: PURPOSE: This meta-analysis aims to evaluate the impact of delaying surgery in operable breast tumor patients after neoadjuvant chemotherapy (NAC) on survival.METHODS: An electronic literature retrieval was conducted on PubMed/Medline and EMBASE((between January 2000 and June 2020).The primary end point was overall survival(OS),secondary end points included disease-free survival (DFS) or recurrence-free survival (RFS).The HR with 95% confidence intervals were calculated using a random-effects or fixed-effects … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…A total of 622 patients were recruited from the Sun Yat-sen Memorial Hospital (SYSMH cohort) of Sun Yat-sen University, a national hospital (Guangzhou, China). The patients consisted of 128 patients from a prospective phase 3 trial (NCT01503905) and 494 patients from an independent retrospective cohort. A total of 381 patients were recruited from the Sun Yat-sen University Cancer Center (SYSUCC cohort), a national hospital (Guangzhou, China); 121 patients from the Shunde Hospital of Southern Medical University (SMUSH cohort) (Foshan, China); and 90 patients from the Tungwah Hospital of Sun Yat-sen University (SYSUTH cohort) (Dongguan, China).…”
Section: Methodsmentioning
confidence: 99%
“…A total of 622 patients were recruited from the Sun Yat-sen Memorial Hospital (SYSMH cohort) of Sun Yat-sen University, a national hospital (Guangzhou, China). The patients consisted of 128 patients from a prospective phase 3 trial (NCT01503905) and 494 patients from an independent retrospective cohort. A total of 381 patients were recruited from the Sun Yat-sen University Cancer Center (SYSUCC cohort), a national hospital (Guangzhou, China); 121 patients from the Shunde Hospital of Southern Medical University (SMUSH cohort) (Foshan, China); and 90 patients from the Tungwah Hospital of Sun Yat-sen University (SYSUTH cohort) (Dongguan, China).…”
Section: Methodsmentioning
confidence: 99%